The Future of Clinical Trials in The UK: Aligning National Assets With Industry Needs

29 Jan 2026
Main Stage
  • What is the current problem with commercial clinical trials in the UK? 
  • How new national infrastructure (e.g. community trial sites, new regulatory pathways) can reduce trial timelines and costs 
  • The role of Our Future Health in providing recruitment and recontact at scale as part of this wider system 
  • Priorities for government, regulators and industry to unlock the full potential in the next 12–24 months 
Speakers
Sir John Bell
Sir John Bell, Chairman - Our Future Health
Dame Anna Dominiczak
Dame Anna Dominiczak, Chief Scientific Adviser (Health) - Scottish Government
Isabel Oliver
Isabel Oliver, Chief Medical Officer - Welsh Government
Lawrence Tallon
Lawrence Tallon, Chief Executive - MHRA
Steve Bates
Steve Bates, Executive Chair - Office for Life Sciences